Analytical Validation of a Telomerase Reverse Transcriptase (TERT) Promoter Mutation Assay

CONCLUSION: The analytical robustness and reproducibility of the Afirma TERT test support its routine clinical use among thyroid nodules with indeterminate cytology that are Afirma GSC suspicious or among Bethesda V/VI nodules.PMID:38441247 | DOI:10.1210/clinem/dgae134

Source: The Journal of Clinical Endocrinology and Metabolism - March 5, 2024 Category: Endocrinology Authors: Priyanka C Iyer Ramona Dadu Anna Barque Cleslei Zanelli Xingyu Zheng Huimin Jiang P Sean Walsh Yangyang Hao Jing Huang Joshua Klopper Richard T Kloos Maria Cabanillas Source Type: research